SRI scientists engineer helper T cells that could become cancer-killers
The cell-based platform uses an often-undervalued subset of helper T cells to deliver antitumor proteins for solid tumors, overcoming dose-related toxicities. MENLO PARK, CA, UNITED STATES, September 30, 2024 /EINPresswire.com/ -- Today’s drug delivery …